Masimo sues U.S. CBP over allowing Apple to reactivate feature, Bloomberg says

In a federal lawsuit filed in the U.S. District Court for the District of Columbia, Masimo (MASI) claimed the U.S. Customs and Border Protection, CBP, unlawfully allowed Apple (AAPL) to reactivate a blood-oxygen tracking feature on its Apple Watches, a feature that infringes on patents for the technology, Christopher Yasiejko of Bloomberg Law reports. Masimo said the CBP quietly reversed its decision without hearing both sides on the topic.